BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7221493)

  • 1. Good response to D-penicillamine in IgA-deficient rheumatoid arthritis.
    Mbuyi-Muamba JM; Stevens E; Dequeker J
    Scand J Rheumatol; 1981; 10(1):31-2. PubMed ID: 7221493
    [No Abstract]   [Full Text] [Related]  

  • 2. IgA deficiency and drug induced IgA deficiency in rheumatoid arthritis.
    Mbuyi JM; Dequeker J; Francx L
    J Rheumatol; 1983 Oct; 10(5):829-31. PubMed ID: 6644713
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent episodes of pseudoseptic arthritis in rheumatoid arthritis: response to D-penicillamine and methotrexate.
    Hunter T
    J Rheumatol; 1992 Sep; 19(9):1484. PubMed ID: 1433023
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating protein complexes in D-penicillamine therapy of rheumatoid arthritis. Correlation between IgG- and alpha 1-antitrypsin-IgA complexes and clinical response.
    Norberg R; Wollheim FA; Gedda PO
    Acta Med Scand; 1980; 208(5):393-6. PubMed ID: 6969974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of patients with rheumatoid arthritis in longterm administration of D-penicillamine.
    Dominkus M; Chlud K; Maida EM; Grisold W
    J Rheumatol; 1992 Oct; 19(10):1648-50. PubMed ID: 1464886
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis.
    Singh RR; Malaviya AN; Malaviya R; Sharma M; Shandilya R; Taneja V; Khare SD; Beri D; Kumar A; Mehra NK
    J Assoc Physicians India; 1994 Mar; 42(3):201-4. PubMed ID: 7860508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [D-penicillamine in the treatment of patients with rheumatoid arthritis].
    Gracheva GV; Erov NK; Romanovskaia LR
    Ter Arkh; 1983; 55(9):94-8. PubMed ID: 6605592
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-immunological analysis of D-penicillamine use in rheumatoid arthritis].
    Benenson EV; Alibekova RI; Seĭsenbaev ASh; Cherkasskiĭ LA; Ivanova RL
    Vopr Revm; 1980; (4):27-31. PubMed ID: 6972667
    [No Abstract]   [Full Text] [Related]  

  • 9. [Case of fibrosing alveolitis (intravital morphological substantiation of the diagnosis) found in a female patient with rheumatoid arthritis being treated with D-penicillamine].
    Baranova IA; Khmel'kova NG
    Revmatologiia (Mosk); 1983; (3):53-5. PubMed ID: 6359349
    [No Abstract]   [Full Text] [Related]  

  • 10. [Eosinophilic fasciitis and IgA deficiency].
    Velasco Domínguez E; Garćia Velasco F; Molinero de Dios J; Barrio Arredondo MT; Fernández Alonso C; Alvarez Gago T; Almaraz Quintana C
    Rev Clin Esp; 1983 Sep; 170(6):287-90. PubMed ID: 6658071
    [No Abstract]   [Full Text] [Related]  

  • 11. [Retrospective study of the effects of D-penicillamine and pyrithioxin in the treatment of rheumatoid arthritis].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):281-7. PubMed ID: 6879095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac involvement in rheumatoid patients before and after D-penicillamine treatment--an echocardiographic study.
    Finch MB; Boyd MW; Dinsmore W; Scott ME
    Ir Med J; 1984 Jun; 77(6):168-70. PubMed ID: 6746255
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of rheumatoid arthritis with kuprenyl (D-penicillamine)].
    Maldyk G; Khvalińska-Sadovska A
    Ter Arkh; 1975; 47(11):107-8. PubMed ID: 1224291
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of rheumatoid arthritis using d-penicillamine].
    Lipa I; Cerimović S; Borovac T
    Med Arh; 1978; 32(2):85-8. PubMed ID: 713621
    [No Abstract]   [Full Text] [Related]  

  • 15. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant rheumatoid polyarthritis with vascular disease: treatment by drugs having an immunodeppressive effect. Study of 5 cases].
    de Sèze S; Debeyre N; Bedoiseau M; Six B; Amouroux J; Kahn MF
    Rev Rhum Mal Osteoartic; 1968; 35(7):406-15. PubMed ID: 5687223
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience in the treatment of rheumatoid arthritis with D-penicillamine].
    Wysocka K; Kiczak J; Hawrylak E
    Wiad Lek; 1980 Apr; 33(8):607-10. PubMed ID: 7405223
    [No Abstract]   [Full Text] [Related]  

  • 18. [D-penicillamine in the treatment of early stages of rheumatoid arthritis].
    Tosković B
    Reumatizam; 1978; 25(4):117-23. PubMed ID: 694252
    [No Abstract]   [Full Text] [Related]  

  • 19. Fenclofenac-induced selective IgA deficiency in rheumatoid arthritis.
    Farr M; Struthers GR; Scott DG; Bacon PA
    Br J Rheumatol; 1985 Nov; 24(4):367-9. PubMed ID: 4063627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Our 1st experiences with the use of D-penicillamine in the treatment of rheumatoid arthritis].
    Pucar I; Dürrigl T
    Lijec Vjesn; 1974 Mar; 96(5):300-4. PubMed ID: 4469807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.